CN102429976A - 一种治疗烧伤、烫伤的中药软膏制剂及其制备方法 - Google Patents
一种治疗烧伤、烫伤的中药软膏制剂及其制备方法 Download PDFInfo
- Publication number
- CN102429976A CN102429976A CN2011104029556A CN201110402955A CN102429976A CN 102429976 A CN102429976 A CN 102429976A CN 2011104029556 A CN2011104029556 A CN 2011104029556A CN 201110402955 A CN201110402955 A CN 201110402955A CN 102429976 A CN102429976 A CN 102429976A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- angelicae dahuricae
- radix angelicae
- burn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 13
- 239000002674 ointment Substances 0.000 title claims abstract description 8
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 23
- 239000007766 cera flava Substances 0.000 claims abstract description 19
- 241000628997 Flos Species 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 23
- 208000002193 Pain Diseases 0.000 abstract description 12
- 230000036407 pain Effects 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 208000008960 Diabetic foot Diseases 0.000 abstract description 6
- 230000003179 granulation Effects 0.000 abstract description 5
- 238000005469 granulation Methods 0.000 abstract description 5
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract description 4
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract description 4
- 230000003115 biocidal effect Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract description 2
- 208000004210 Pressure Ulcer Diseases 0.000 abstract description 2
- 229940116229 borneol Drugs 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 240000001972 Gardenia jasminoides Species 0.000 abstract 1
- 208000008469 Peptic Ulcer Diseases 0.000 abstract 1
- 235000019606 astringent taste Nutrition 0.000 abstract 1
- 235000013871 bee wax Nutrition 0.000 abstract 1
- 239000012166 beeswax Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 abstract 1
- 208000011906 peptic ulcer disease Diseases 0.000 abstract 1
- 239000008159 sesame oil Substances 0.000 abstract 1
- 235000011803 sesame oil Nutrition 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 33
- 208000027418 Wounds and injury Diseases 0.000 description 33
- 208000025865 Ulcer Diseases 0.000 description 12
- 231100000397 ulcer Toxicity 0.000 description 12
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 8
- 229960004306 sulfadiazine Drugs 0.000 description 8
- 230000029663 wound healing Effects 0.000 description 8
- 210000000589 cicatrix Anatomy 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000008929 regeneration Effects 0.000 description 5
- 238000011069 regeneration method Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- IGWDEVSBEKYORK-UHFFFAOYSA-N isoimperatorin Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)C IGWDEVSBEKYORK-UHFFFAOYSA-N 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 241000157835 Gardenia Species 0.000 description 3
- 241000245240 Lonicera Species 0.000 description 3
- 241000545442 Radix Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- -1 flavone compound Chemical class 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- QTAGQHZOLRFCBU-CYBMUJFWSA-N (+)-oxypeucedanin Chemical compound CC1(C)O[C@@H]1COC1=C(C=CO2)C2=CC2=C1C=CC(=O)O2 QTAGQHZOLRFCBU-CYBMUJFWSA-N 0.000 description 2
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 2
- ZPSAEGUNYMEKBP-UHFFFAOYSA-N 5-Isopentenyloxy-psoralen Natural products CC(C)C=COc1c2C=CC(=O)Oc2cc3occc13 ZPSAEGUNYMEKBP-UHFFFAOYSA-N 0.000 description 2
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 2
- BEYIWVKWKJROGZ-UHFFFAOYSA-N Alloimperatorin Natural products O1C(=O)C=CC2=C1C(O)=C1OC=CC1=C2OCC=C(C)C BEYIWVKWKJROGZ-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 description 2
- DTGKSKDOIYIVQL-MRTMQBJTSA-N Isoborneol Natural products C1C[C@@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-MRTMQBJTSA-N 0.000 description 2
- KGGUASRIGLRPAX-UHFFFAOYSA-N Meranzin hydrate Natural products C1=CC(=O)OC2=C(CC(O)C(C)(C)O)C(OC)=CC=C21 KGGUASRIGLRPAX-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- QTAGQHZOLRFCBU-UHFFFAOYSA-N Oxypeucadanin Natural products CC1(C)OC1COC1=C(C=CO2)C2=CC2=C1C=CC(=O)O2 QTAGQHZOLRFCBU-UHFFFAOYSA-N 0.000 description 2
- NUCBCBCPICFGMZ-UHFFFAOYSA-N Oxypeucedanin Natural products CC1(C)OC1COC1=CC(=O)OC2=C1C=C1C=COC1=C2 NUCBCBCPICFGMZ-UHFFFAOYSA-N 0.000 description 2
- MWEVYJRFLDKUCW-UHFFFAOYSA-N Oxypeucedonin-hydrat Natural products CC(C)(O)C(O)Cc1c2C=CC(=O)Oc2cc3occc13 MWEVYJRFLDKUCW-UHFFFAOYSA-N 0.000 description 2
- BMLZFLQMBMYVHG-UHFFFAOYSA-N Phellopterin Chemical compound O1C(=O)C=CC2=C1C(OCC=C(C)C)=C1OC=CC1=C2OC BMLZFLQMBMYVHG-UHFFFAOYSA-N 0.000 description 2
- XXARIFJTXNCWNT-UHFFFAOYSA-N Phellopterin Natural products COc1c2C=CC(=O)Oc2c(OC=CC(C)C)c3occc13 XXARIFJTXNCWNT-UHFFFAOYSA-N 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- UZXMLGUMBQQVME-UHFFFAOYSA-N Swietenocoumarin B Natural products O1C(=O)C=CC2=C1C(CC=C(C)C)=C1OC=CC1=C2OC UZXMLGUMBQQVME-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000910 agglutinin Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000001126 granulation tissue Anatomy 0.000 description 2
- OLOOJGVNMBJLLR-UHFFFAOYSA-N imperatorin Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OCC=C(C)C OLOOJGVNMBJLLR-UHFFFAOYSA-N 0.000 description 2
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002690 local anesthesia Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- HRWVKZXRZVVBLP-UHFFFAOYSA-N oxypeucedanin hydrate Natural products CC(C)(O)C(O)CCc1c2C=CC(=O)Oc2cc3occc13 HRWVKZXRZVVBLP-UHFFFAOYSA-N 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CJGSNPCDEYCMDA-UHFFFAOYSA-N 2-[(dimethylamino)methyl]-4-fluoro-6-methylphenol Chemical compound CN(C)CC1=CC(F)=CC(C)=C1O CJGSNPCDEYCMDA-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- PFCVZKFJHRCLCC-MTYXOXLRSA-N Alphitolic acid Natural products CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@@H](CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O PFCVZKFJHRCLCC-MTYXOXLRSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RTIXKCRFFJGDFG-UHFFFAOYSA-N Chrysin Natural products C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010021718 Induced labour Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- PSZDOEIIIJFCFE-UHFFFAOYSA-N Oleanolic alcohol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C)(C)CC5C4=CCC3C21C PSZDOEIIIJFCFE-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- FGUBFGWYEYFGRK-HNNXBMFYSA-N Pinocembrin Natural products Cc1cc(C)c2C(=O)C[C@H](Oc2c1)c3ccccc3 FGUBFGWYEYFGRK-HNNXBMFYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960002045 bergapten Drugs 0.000 description 1
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- PSZDOEIIIJFCFE-OSQDELBUSA-N erythrodiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C PSZDOEIIIJFCFE-OSQDELBUSA-N 0.000 description 1
- HTZRWCSRPTWJCT-UHFFFAOYSA-N erythrodiol Natural products CC1(C)CCC2(CO)CCC3C(CCC4C3(C)CCC5C(C)(C)C(O)CCC45C)C2C1 HTZRWCSRPTWJCT-UHFFFAOYSA-N 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000037189 immune system physiology Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- SWUARLUWKZWEBQ-VQHVLOKHSA-N phenethyl caffeate Chemical compound C1=C(O)C(O)=CC=C1\C=C\C(=O)OCCC1=CC=CC=C1 SWUARLUWKZWEBQ-VQHVLOKHSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- URFCJEUYXNAHFI-ZDUSSCGKSA-N pinocembrin Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=CC=C1 URFCJEUYXNAHFI-ZDUSSCGKSA-N 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种治疗烧伤、烫伤的中药软膏制剂及其制备方法。软膏制剂由下述重量配比的原料组成:栀子18-20份、金银花8-10份、白芷20-24份、冰片5份、蜂蜡160-200份、麻油800-1000份,其制备方法:栀子、白芷放入麻油中,浸渍24小时,文火煎熬至白芷枯黄为度,再加入金银花,保持油温半小时,除去药渣,滤过,加入蜂蜡,搅拌使熔化,至55℃~60℃,将研细的冰片加入,搅匀至冷却即可。本发明用于各种烧伤、烫伤,可有效起到抗菌、滋润、收敛、止痛、生肌等治疗作用,还对褥疮、糖尿病足、消化道溃疡具有一定疗效,是一种生产工艺简单,质量指标易控,使用方便,安全有效的中药软膏制剂。
Description
技术领域
本发明涉及中医药领域,具体涉及一种治疗烧伤、烫伤的中药软膏制剂及其制备方法。
背景技术
烧烫伤是一种常见性外伤,无论其面积的大小,由于皮肤破溃导致机体的第一道屏障破坏,细菌可直接进入人体。如果烧烫伤面积较大由于体液的丧失则其病理、生理相当复杂,重者危及生命、轻者创面愈合时间长短不一,其中一个典型特点是感染的可能性基本贯穿整个病程,而且烧伤较严重者愈后有严重的疤痕,因此,如何处理创面是治疗烧伤的关键。
发明内容
为解决上述技术问题,本发明提供一种治疗烧伤、烫伤的中药软膏制剂及其制备方法,其具有清热解毒、消肿排脓、清热止痛、生肌敛疮等功效,且生产工艺简单,质量指标易控,使用方便,安全有效,其次本中药软膏制剂对糖尿病足、消化道溃疡也有一定疗效,具有再生功能。
本发明解决上述技术问题的技术方案是:它由下述重量配比的原料制成:栀子18-20份、金银花8-10份、白芷20-24份、冰片5份、蜂蜡160-200份、麻油800-1000份。
一种治疗烧伤、烫伤的中药软膏制剂的制备方法,包括以下步骤:将栀子、白芷放入麻油中,浸渍24小时,用文火煎熬至药枯为度,再加入金银花,保持油温半小时,除去药渣,滤过,加入蜂蜡,搅拌使熔化,待冷至55℃~60℃,将研细的冰片加入,充分搅匀至冷却,即为软膏。
本发明中主要成分的药理机理是:蜂腊的成分相当复杂,主要成分是黄酮类化合物,此外还有酚类、醇类、酸类、脂类等多种化合物,少量的铁、钙、镉、硅、锰、铅、锡、镍、锌等微量元素以及维生素B、维生素A、多种氨基酸、酶、阿魏酸等。蜂腊的功效:1)具有广谱抗菌作用 。在蜜蜂群居的蜂箱或树穴内,适宜的气温和温度并未导致微生物生长,大量繁殖,研究证实,是蜂腊起了重要的作用。蜂腊能抑制多种细菌和某些病毒的生长,具有广谱抗生素作用。 蜂腊乙醇浸出物100μg/ml浓度对39种细菌中的25种和39种植物真菌中的20种都有抑制作用,其中对革兰氏阳性细菌和抗酸菌最为敏感。2)促进机体免疫功能。用蜂腊注入小白鼠、家鼠、猪和牛犊体内,能促进机体的免疫过程。能刺激免疫机能、刺激H-凝集素合成和O-凝集素的增生效应,增加抗体产量和增加巨噬细胞活力,使血管局部抗感染能力也随之升高。3 )组织再生促进剂。 蜂腊能加速被损伤的软骨和组织的再生过程。对损伤有刺激再生作用,促进循环障碍的恢复,刺激胶原纤维桥形成。参加促进细胞生长和分裂,加快受伤组织修复和愈合。4)局部麻醉作用 实验证明,用4%蜂腊乙醇溶液加水稀释到0.25%的浓度对兔角膜的麻醉效应可持续1h,比普鲁卡因作用强。蜂腊成分中的松属素、松球素和咖啡酸酯的温合物等有较强的局部麻醉作用,能有效对抗烧伤创面引起的局部疼痛。
中医认为冰片味辛苦,性凉,有开窍醒神、清热止痛、生肌之效。其化学成分为:龙脑冰片含右旋龙脑,又含葎草烯、β-榄香烯、石竹烯等倍半萜,以及齐墩果酸、麦珠子酸、积雪草酸、龙脑香醇、古柯二醇等三萜化合物。艾片含左旋龙脑。机制冰片为消旋混合龙脑。冰片的药理作用:冰片中的主要成分龙脑、异龙脑均有耐缺氧的作用;龙脑、异龙脑有镇静作用;冰片局部应用对感觉神经有轻微刺激,有一定的止痛及温和的防腐作用;经肠系膜吸收迅速,给药5分钟即可通过血脑屏障,且在脑蓄积时间长,量也相当高,此为冰片的芳香开窍作用提供了初步实验依据;较高浓度(0.5%)对葡输球菌、链球菌、肺炎双球茵、大肠杆菌及部分致病性皮肤真菌等有抑制作用;对中、晚期妊娠小鼠有引产作用。
白芷性味:性温、味辛, 功能主治祛风湿,活血排脓,生肌止痛。用于头痛、牙痛、鼻渊、肠风痔漏、赤白带下、痈疽疮疡、皮肤瘙痒。 白芷含异欧前胡素(isoimperatorin)、欧前胡素(imperatorin)、佛手柑内酯(bergapten)、珊瑚菜素(phellopterin)、氧化前胡素(oxypeucedanin)等。
栀子性味:苦,寒。功能主治:清热,泻火,凉血。治热病虚烦不眠,黄疸,淋病,消渴,目赤,咽痛,吐血,衄血,血痢,尿血,热毒疮疡,扭伤肿痛。
本发明的技术效果是:本发明的配方中,栀子泻火除烦、清热利湿、凉血解毒、消肿止痛;金银花清热解毒、疏散风热;白芷祛风止痛、消肿排脓;冰片开窍醒神、清热止痛;蜂蜡解毒、敛疮、生肌、止痛。各药合用,所成软膏剂具有清热解毒、消肿排脓、清热止痛、生肌敛疮等功效,且其生产工艺简单,质量指标易控,使用方便,安全有效。本发明用于各种烧伤、烫伤,由于形成保护膜、保护创面、防止体液外渗;此膜形成隔离层,阻止外界细菌直接进入创面,可有效起到抗菌、滋润、收敛、止痛、生肌等治疗作用,疗效确切;其次本发明还对糖尿病足、消化道溃疡具有一定疗效,其可预防和控制糖尿病足的感染,促进患者肉芽组织生长,并实现消化道溃疡患者的黏膜组织的生理性修复与再生。
具体实施方式
实施例1:治疗烧伤、烫伤的中药软膏制剂由下述重量配比的原料制成:栀子18份、金银花8份、白芷24份、冰片5份;蜂蜡200份、麻油800份。
上述治疗烧伤、烫伤的中药软膏制剂的制备方法为:将栀子、白芷放入麻油中,浸渍24小时,用文火煎熬至药枯为度,再加入金银花,保持油温半小时,除去药渣,滤过,加入蜂蜡,搅拌使熔化,待冷至55℃,将研细的冰片加入,充分搅匀至冷却,即为软膏。
实施例2:治疗烧伤、烫伤的中药软膏制剂由下述重量配比的原料制成:栀子20份、金银花10份、白芷20份、冰片5份、蜂蜡160份、麻油1000份。制备方法同实施例1不同之处仅在于:冷却至60℃再将研细的冰片加入。
实施例3:治疗烧伤、烫伤的中药软膏制剂由下述重量配比的原料制成:栀子19份、金银花9份、白芷22份、冰片5份;蜂蜡180份、麻油900份。制备方法同实施例1不同之处仅在于:冷却至58℃再将研细的冰片加入。
下面为本发明与磺胺嘧啶银的多种对比试验实例,其结果如下:
1.患者本人不同烧伤部位的对比。
同一患者取不同烧伤部位分别采取磺胺嘧啶银粉、本发明予以外敷。将磺胺嘧啶银粉加入生理盐水外敷创面,3天换药一次;将本发明外敷另一创面,一天换药一次。换药前创面均采取同样消毒方法。结果表明:采取本发明后,其创面液化时间缩短2~5天。而且使用本发明的创面恢复后,基本无疤痕形成或者部分形成疤痕,但要比对比侧少。
2.患者本人相对称烧伤部位的对比。
同一患者取相对称的烧伤部位分别采取磺胺嘧啶银粉、本发明予以外敷。将磺胺嘧啶银粉加入生理盐水外敷创面,3天换药一次;将本发明外敷另一创面,一天换药一次。换药前创面均采取同样消毒方法。结果表明:采取本发明后,其创面液化时间缩短2~5天。而且使用本发明的创面恢复后,基本无疤痕形成或者部分形成疤痕,但要比对侧少。
3.不同年龄相同烧伤部位的对比。
不同年龄患者相同的烧伤部位分别采取磺胺嘧啶银粉、本发明予以外敷。将磺胺嘧啶银粉加入生理盐水外敷创面,3天换药一次;将本发明外敷另一患者相同部位的创面,一天换药一次。换药前创面均采取同样消毒方法。结果表明:采取本发明后,其创面液化时间缩短3~6天。而且使用本发明的创面恢复后,基本无疤痕形成或者部分形成疤痕,但要比对比方少。
4.相同年龄相同烧伤部位的对比。
相同年龄患者相同的烧伤部位分别采取磺胺嘧啶银粉、本发明予以外敷。将磺胺嘧啶银粉加入生理盐水外敷创面,3天换药一次;将本发明外敷另一患者相同部位的创面,一天换药一次。换药前创面均采取同样消毒方法。结果表明:采取本发明后,其创面液化时间缩短3~6天。而且使用本发明的创面恢复后,基本无疤痕形成或者部分形成疤痕,但要比对比方少。
下面为使用本发明后,对不同烧伤程度以及褥疮、糖尿病足、消化道溃疡病患进行临床疗效观察。
1.烧烫伤面积在10%以下的疗效。
除10岁以下的小孩以外,使用本发明后,一般可以门诊治疗,而且只要口服抗生素即可,部分患者甚至不需要抗炎治疗。其创面恢复后,基本无疤痕形成(疤痕体质除外)。此类患者每年约300例。
2.烫伤面积在20%~70%的疗效。
此类患者需住院治疗。每天使用本发明一次,外敷本发明后将创面包扎(最好能无菌技术操作)。其他予以对症补液、抗炎1周治疗即可。创面液化后,一般能形成新的皮岛,创面愈合。部分患者需皮肤移植术。创面愈合时间8天至30余天不等。此类患者每年收治约400例。
3.烧烫伤程度在深二度以下的疗效。
烧烫伤程度在深二度以下的创面,使用本发明后,创面液化后,一般能形成新的皮岛,创面愈合。无疤痕形成。
4.烧烫伤程度在深二度以上的疗效。
烧烫伤程度在深二度以上的创面,使用本发明后,创面液化时间稍长,创面愈合时间20天至40余天不等。少数能形成新的皮岛,创面愈合。部分有疤痕形成。
5.对褥疮的疗效。
对于褥疮创面的消毒或清洗要求不高,有条件者可在络合碘消毒后使用,无条件者可在盐茶水清洗后予以外搽。每天两次即可。创面愈合时间较短(5天~20天不等),疗效确切。
6. 对糖尿病足的疗效。
对于糖尿病足患者,将本发明外用,每3-4小时一次,可预防和控制感染,促进肉芽组织生长,加速伤口愈合,疗效确切。
7.对于消化道溃疡的疗效。
对于消化道溃疡患者,口服本发明后能改善胃肠道功能,对常见胃部病疫、胃粘膜有辅助保护作用、润肠通便,原位再生新的黏膜组织器官,复原胃肠黏膜器官,既可保护人体正常的胃肠黏膜,又能激活、促进胃肠黏膜原位干细胞再生复制,实现黏膜组织的生理性修复与再生。
Claims (2)
1.一种治疗烧伤、烫伤等的中药软膏制剂,它由下述重量配比的原料制成:栀子18-20份、金银花8-10份、白芷20-24份、冰片5份、蜂蜡160-200份、麻油800-1000份。
2.一种治疗烧伤、烫伤的中药软膏制剂的制备方法,包括以下步骤:将栀子、白芷放入麻油中,浸渍24小时,用文火煎熬至白芷枯黄为度,再加入金银花,保持油温半小时,除去药渣,滤过,加入蜂蜡,搅拌使熔化,待冷至55℃~60℃,将研细的冰片加入,充分搅匀至冷却,即为软膏。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011104029556A CN102429976A (zh) | 2011-12-07 | 2011-12-07 | 一种治疗烧伤、烫伤的中药软膏制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011104029556A CN102429976A (zh) | 2011-12-07 | 2011-12-07 | 一种治疗烧伤、烫伤的中药软膏制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102429976A true CN102429976A (zh) | 2012-05-02 |
Family
ID=45978561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011104029556A Pending CN102429976A (zh) | 2011-12-07 | 2011-12-07 | 一种治疗烧伤、烫伤的中药软膏制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102429976A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107397813A (zh) * | 2017-07-29 | 2017-11-28 | 王明前 | 一种治疗烧烫伤的中药散剂 |
CN108635399A (zh) * | 2018-08-02 | 2018-10-12 | 董云千 | 一种烫伤膏及其制备方法和应用 |
CN114177267A (zh) * | 2022-01-18 | 2022-03-15 | 冯树 | 一种用于治疗烫伤和褥疮的膏药及其制备方法 |
CN115737720A (zh) * | 2022-11-25 | 2023-03-07 | 麦莩医疗器械(武汉)有限公司 | 一种抑菌膏组合物及其制备方法与应用 |
-
2011
- 2011-12-07 CN CN2011104029556A patent/CN102429976A/zh active Pending
Non-Patent Citations (1)
Title |
---|
马振友: "《皮肤美容化妆品制剂手册》", 31 March 2004 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107397813A (zh) * | 2017-07-29 | 2017-11-28 | 王明前 | 一种治疗烧烫伤的中药散剂 |
CN108635399A (zh) * | 2018-08-02 | 2018-10-12 | 董云千 | 一种烫伤膏及其制备方法和应用 |
CN114177267A (zh) * | 2022-01-18 | 2022-03-15 | 冯树 | 一种用于治疗烫伤和褥疮的膏药及其制备方法 |
CN115737720A (zh) * | 2022-11-25 | 2023-03-07 | 麦莩医疗器械(武汉)有限公司 | 一种抑菌膏组合物及其制备方法与应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102327478B (zh) | 一种治疗烧烫伤的药物组合物及其制备方法 | |
CN104288504B (zh) | 一种治疗烧伤、烫伤的中药软膏制剂及其制备方法 | |
CN102429976A (zh) | 一种治疗烧伤、烫伤的中药软膏制剂及其制备方法 | |
CN101632754B (zh) | 一种治疗咽炎的中药组合物及其制备方法 | |
CN102357164B (zh) | 一种临床护理烧伤的药物组合物及其制备方法 | |
CN101703651A (zh) | 一种治疗糖尿病坏疽的药物 | |
CN102784316B (zh) | 治烧烫伤、内外溃疡、白内障的抑癌生肌药及其制备方法 | |
CN104491107A (zh) | 治疗烧伤的中药制剂及其制备方法 | |
CN101708253B (zh) | 痱子粉 | |
CN102430036A (zh) | 烧烫伤抗菌止痛膏 | |
CN107007761B (zh) | 一种中药烧伤油及其制备方法 | |
CN104815068A (zh) | 一种头孢氨苄软膏及制备方法 | |
CN100502894C (zh) | 一种藏青果提取的有效部位用于细菌和病毒感染性疾病的药物的制备方法和应用 | |
CN100444887C (zh) | 一种组合物在制备治疗冻疮疾病药物中的应用 | |
CN100355437C (zh) | 一种治疗烧烫伤的药物及其制备方法 | |
CN105770347A (zh) | 一种纯中药配方的烧烫创疡油及其制备方法 | |
CN102028771A (zh) | 一种紫红疡油膏 | |
CN111920883A (zh) | 一种治疗带状疱疹的外用制剂及其制备方法 | |
CN105213733A (zh) | 一种创面修复中药肥皂及其制备方法 | |
CN104922614A (zh) | 一种中药褥疮膏 | |
CN103181964B (zh) | 治疗动物体表创伤的中药组合物及其制备方法 | |
CN108186864A (zh) | 一种治疗痤疮的中药 | |
CN108245577B (zh) | 一种烧伤止痛消肿生肌液膏及其制备方法 | |
CN101491599B (zh) | 一种化输尿管结石的复方石韦金钱草汤 | |
CN102100727A (zh) | 一种治疗动物腐蹄病的中药粉剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120502 |